Intervention approaches in early lung cancer and premalignant disease: breakout group report.
Ihde
D C
DC
Office of the Director, National Cancer Institute, Bethesda, Maryland 20892.
Lippman
S
S
D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D008175:Lung Neoplasms / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000628:therapy
D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor